Last reviewed · How we verify
MEPIVACAÍNE
Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses. Used for Local and regional anesthesia for dental procedures, Local and regional anesthesia for minor surgical procedures, Infiltration anesthesia.
At a glance
| Generic name | MEPIVACAÍNE |
|---|---|
| Also known as | MEPIVACAINE 2% ATC N01BB03 MAN 62606 |
| Sponsor | Complexo Hospitalario Universitario de A Coruña |
| Drug class | Local anesthetic (amide) |
| Target | Voltage-gated sodium channels |
| Modality | Small molecule |
| Therapeutic area | Anesthesia |
| Phase | FDA-approved |
Mechanism of action
Mepivacaine reversibly inhibits sodium influx into nerve fibers by binding to sodium channels from the intracellular side, thereby stabilizing the neuronal membrane and raising the threshold for electrical excitability. This action prevents depolarization and propagation of action potentials, resulting in local anesthesia. The drug is an amide-type local anesthetic with intermediate duration of action.
Approved indications
- Local and regional anesthesia for dental procedures
- Local and regional anesthesia for minor surgical procedures
- Infiltration anesthesia
Common side effects
- Paresthesia
- Headache
- Dizziness
- Nervousness
- Allergic reactions (rare with amides)
Key clinical trials
- Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research. (PHASE4)
- Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |